Prescribing Information & Guidance

Resources For Health Professionals


Rybelsus® (oral Semaglutide) Tablets


This guidance includes information relating to the switching from injectable GLP1 Receptor agonists to oral semaglutide

Approved by the BLMK APC Feb 2023

View Document

Guideline Categories: Endocrinology and Diabetes

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: GLP1 receptor agonists, GLP1-RAs, semaglutide, switching

Please use the search box to search the whole site if you can't find what you're looking for:

To top